Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-016854

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mary Z. Luo
Officer — COO, Chief Scientist, Chairman · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Science Officer · Director · 10% Owner
Period of report
Mar 26, 2016
Accepted (ET)
Mar 29, 2016 · 7:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 26, 2016F15,711$11.96D1,114,191D
Common StockF1Mar 27, 2016F25,856$11.96D1,088,335D
Common StockF1,F2Mar 26, 2016F6,704$11.96D760,962ISee footnote
Common StockF1,F2Mar 27, 2016F8,641$11.96D752,321ISee footnote
Common StockF3holding———7,461,594ISee footnote
Common StockF4holding———5,000ISee footnote
Common StockF5holding———200,000ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses